- Home
- POET vs XOMA Comparison
POET vs XOMA Comparison
Compare POET & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- XOMA
- Stock Information
- Founded
- POET 1972
- XOMA 1981
- Country
- POET Canada
- XOMA United States
- Employees
- POET N/A
- XOMA N/A
- Industry
- POET Semiconductors
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- POET Technology
- XOMA Health Care
- Exchange
- POET Nasdaq
- XOMA Nasdaq
- Market Cap
- POET 366.1M
- XOMA 300.5M
- IPO Year
- POET N/A
- XOMA N/A
- Fundamental
- Price
- POET $4.03
- XOMA $24.05
- Analyst Decision
- POET Strong Buy
- XOMA Strong Buy
- Analyst Count
- POET 2
- XOMA 2
- Target Price
- POET $6.25
- XOMA $69.50
- AVG Volume (30 Days)
- POET 856.4K
- XOMA 40.4K
- Earning Date
- POET 08-13-2025
- XOMA 08-12-2025
- Dividend Yield
- POET N/A
- XOMA N/A
- EPS Growth
- POET N/A
- XOMA N/A
- EPS
- POET N/A
- XOMA N/A
- Revenue
- POET $199,477.00
- XOMA $42,909,000.00
- Revenue This Year
- POET $8,377.56
- XOMA $70.91
- Revenue Next Year
- POET $1,061.73
- XOMA $14.00
- P/E Ratio
- POET N/A
- XOMA N/A
- Revenue Growth
- POET N/A
- XOMA 638.41
- 52 Week Low
- POET $1.69
- XOMA $18.35
- 52 Week High
- POET $7.79
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- POET 43.46
- XOMA 45.38
- Support Level
- POET $4.02
- XOMA $23.51
- Resistance Level
- POET $4.30
- XOMA $24.65
- Average True Range (ATR)
- POET 0.19
- XOMA 1.10
- MACD
- POET -0.03
- XOMA -0.17
- Stochastic Oscillator
- POET 7.02
- XOMA 20.92
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.